Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The recent appearance of osteonecrosis of the jaw in cancer patients receiving intravenous (IV) bisphosphonates is a painful reminder of the condition that struck match factory workers over a hundred years ago.

Drug Criteria & Outcomes: Bad to the (jaw) bone: